First Hawaiian Bank Grows Stake in Humana Inc. $HUM

Key Points

• First Hawaiian Bank increased its holdings in Humana Inc. by 9.2%, bringing their total to 13,811 shares, valued at approximately $3.65 million, according to a recent SEC filing.
• Humana's stock price opened at $279.04, with an annual performance showing a 12-month low of $206.87 and a high of $331.00.
• The company recently announced a quarterly dividend of $0.885, to be paid on October 31st, representing a 1.3% yield based on an annual dividend payout ratio of 27.17%.

First Hawaiian Bank boosted its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 9.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,811 shares of the insurance provider's stock after buying an additional 1,164 shares during the period. First Hawaiian Bank's holdings in Humana were worth $3,654,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC bought a new position in Humana during the first quarter valued at approximately $1,309,000. Envestnet Asset Management Inc. boosted its stake in Humana by 2.4% during the first quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider's stock valued at $33,256,000 after buying an additional 2,950 shares during the last quarter. Circle Wealth Management LLC bought a new position in Humana during the first quarter valued at approximately $425,000. Rhumbline Advisers boosted its stake in Humana by 3.3% during the first quarter. Rhumbline Advisers now owns 246,037 shares of the insurance provider's stock valued at $65,101,000 after buying an additional 7,909 shares during the last quarter. Finally, Arizona State Retirement System boosted its stake in Humana by 3.4% during the first quarter. Arizona State Retirement System now owns 35,337 shares of the insurance provider's stock valued at $9,350,000 after buying an additional 1,165 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on HUM shares. Robert W. Baird lowered their price objective on Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Barclays raised their price objective on Humana from $275.00 to $315.00 and gave the company an "equal weight" rating in a research note on Friday, September 5th. Royal Bank Of Canada raised their price objective on Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a research note on Thursday, August 21st. Morgan Stanley lowered their price objective on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Finally, Truist Financial lowered their price objective on Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Seven analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. Based on data from MarketBeat, Humana presently has an average rating of "Hold" and a consensus target price of $289.24.

Humana Trading Down 0.8%

Shares of NYSE HUM traded down $2.36 during midday trading on Friday, hitting $276.36. The company's stock had a trading volume of 1,138,341 shares, compared to its average volume of 1,618,744. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The business's 50 day moving average is $265.34 and its two-hundred day moving average is $257.17. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $325.75. The firm has a market cap of $33.24 billion, a P/E ratio of 21.21, a price-to-earnings-growth ratio of 1.62 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The business had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. During the same quarter in the previous year, the company posted $6.96 earnings per share. The company's quarterly revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio (DPR) is presently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.